Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. In some cases, it prevents the heart from relaxing and filling with blood as it should.
This report contains market size and forecasts of Dilated Cardiomyopathy Therapeutics in Global, including the following market information:
Global Dilated Cardiomyopathy Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dilated Cardiomyopathy Therapeutics market was valued at 28 million in 2021 and is projected to reach US$ 33 million by 2028, at a CAGR of 2.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Class Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dilated Cardiomyopathy Therapeutics include Aastrom Biosciences, Capricor Therapeutics, GlaxoSmithkline Plc, Johnson and Johnson, Kasiak Research Pvt. Ltd., Merck & Co., Inc., MyoKardia, Pfizer, Inc., t2cure, GmbH and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dilated Cardiomyopathy Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dilated Cardiomyopathy Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dilated Cardiomyopathy Therapeutics Market Segment Percentages, by Type, 2021 (%)
Drug Class
Implantable Device
Pipeline Analysis
Global Dilated Cardiomyopathy Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dilated Cardiomyopathy Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Dilated Cardiomyopathy Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dilated Cardiomyopathy Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dilated Cardiomyopathy Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dilated Cardiomyopathy Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aastrom Biosciences
Capricor Therapeutics
GlaxoSmithkline Plc
Johnson and Johnson
Kasiak Research Pvt. Ltd.
Merck & Co., Inc.
MyoKardia, Pfizer, Inc.
t2cure, GmbH
Teva Pharmaceutical Industries
ZensunSci & Tech